Member Info for CHELSEA7

From 12.15 at 21p

89 Trades

From 11.55 showing as a sell but looks like a buy to me.

C11, would you like tomatoes with that??

20.50/21.50 -2.33%........................All the way to blue as support kicks in again.

20/50/21 -3.49%......................looking good to get back to 22p

For 5k, and then we tick down to 20/21 again, but another 50k buy in at 20.90.

And again 20/21.50 -3.49%

Bid should tick up soon too.

20/21......................Buys 100k, 49k and 73k at 21.38, 21.40 and 21.425

And 77 trades............................yesterday was 1.5m and 66 trades

Another 20/20.50 -5.81%......................looks like more to come.

19.80/20.50 -6.95%

Wish I could buy, lol

125k Buy at 20.10 and 20.20 being paid

60 Trades

100k and 50k respectively, comeback on..........................hopefully

Delayed buy for 149k, support kicking in?

Agree about Redmile hasiba, which is why I retain confidence.

Something TF said in reply to autonomy yesterday I disagree with, it suggested we know as much as Redmile do, and despite many debates on this very subject I really do not think we know anything near as to what they do.

A busy seller 4 x 100k sells 20.26-20-15 in 2 minutes.

Support?

Traded today, 82 trades well up, just seems like a few more PIs are shedding a few.

Goodnight

Equally true Krafty and I think it is worth noting that when recruitment started we were just entering into the beginning of the COVID virus starting. My only concern there is we never recruited any patients. Perhaps we have had to rethink not only the endpoints of the trial but who qualifies as a patient able to recruit.

My only surprise is that we have held up so well in recent times, but whether new is due or late it doesn"t do much for sentiment to hear nothing.

I just feel that was is being perceived as being very slow stems from the media reports that stated trials would start within weeks. I am also researching the "n" protein, as all the approved vaccines concentrated on that, I guess it was proven and hope that Lindy is doing ground breaking work on a very different approach which will go some way about concerns over future mutations and variants.

So to me H2 means H2, and more is my immediate hope that we get updates not just on the SCIB1 Combo Trial or COVIDITY but on Moditope too, and I can only imagine we are better placed by the huge reduction in CVID 19 figures to strt recruitment on all cancer platforms. Take care.